Immunity to RSV in Early-Life

Area of Science:

• Immunology
• Pediatrics
• Virology

Background:

• Respiratory Syncytial Virus (RSV) is a leading cause of infant hospitalizations and deaths globally.
• Infant age is the primary risk factor for severe RSV-induced bronchiolitis.
• Age-related immune response differences significantly impact RSV infection outcomes in infants.

Purpose of the Study:

• To explore age-related immune response variations to RSV in infants.
• To understand the immunological basis of RSV bronchiolitis severity.
• To inform the development of effective RSV vaccines and therapies for infants.

Main Methods:

• Analysis of age-dependent innate and adaptive immune responses to RSV.
• Investigation of cytokine profiles and T cell polarization in infants.
• Examination of genetic factors influencing RSV bronchiolitis susceptibility.

Main Results:

• Infants exhibit distinct innate cytokine responses and T cell polarization (Th2/Th17 bias) compared to adults.
• Genetic polymorphisms in early innate response genes correlate with bronchiolitis.
• Immature T follicular helper and B cell responses in infants, alongside poor adult immunity, pose vaccination challenges.

Conclusions:

• Age-related immune immaturity is central to severe RSV disease and bronchiolitis in infants.
• Maternal vaccination is a potential strategy, but challenges in achieving protective immunity persist.
• Further research into immune maturation is crucial for designing effective RSV vaccines and treatments.